CCO Infectious Disease Podcast

Stream this podcast to learn from experts Tessa Rife-Pennington, PharmD, BCGP, and Frank North, PharmD, MPA, DPLA, DASPL, how specialty pharmacists can apply practical strategies within different pharmacy settings to overcome barriers to PrEP use, especially among underserved patient subpopulations. Topics covered include:PrEP candidacy Selection of individualized regimensKey barriers to PrEP useStrategies for overcoming key barriers to PrEP accessEvolving state-based legislation on PrEP provision by pharmacistsModels of pharmacy-managed PrEPStrategies for addressing inequities in PrEP careComprehensive HIV prevention servicesPresenters:Tessa Rife-Pennington, PharmD, BCGPDr. Dawn K. Smith HIV Prevention Clinical FellowAmerican Academy of HIV MedicineVolunteer Assistant Clinical ProfessorUniversity of California, San Francisco, School of PharmacySan Francisco, CaliforniaFrank North, PharmD, MPA, DPLA, DASPLInstructional Assistant Professor, Irma Lerma Rangel College of PharmacyDirector of Learning in PracticeOffice of Interprofessional Practice, Education and ResearchTexas A&M University Health Science CenterPast President, National Pharmaceutical AssociationCollege Station, TexasLink to full program: https://bit.ly/49SLc0yGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, expert patient navigators Shellye Jones and Lauren Jackson discuss the key take-home points of our online educational program on facilitating engagement in HIV care and propose a framework for effectively retaining people in care. Topics covered include: How to approach a patient with complex barriers to engagement in healthcareResources for staying in care, such as wraparound servicesSetting SMART goals and formulating action plans with patientsDeconstructing stigma and implementing a trauma-informed approach to carePresenters:Shellye Jones, MSW, LCSWClinical SupervisorCharles R. Drew University, Drew CARESLos Angeles, CaliforniaLauren Harris JacksonStreet Medicine Patient NavigatorHealthcare in ActionLos Angeles, CaliforniaLink to full program: https://bit.ly/3Wh4Z1TGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Don’t settle! Listen in to learn how a proactive approach to ART switch can improve treatment satisfaction and quality of life for people living with virologically suppressed HIV. Topics covered include:International AIDS Society (IAS) USA and European AIDS Clinical Society (EACS) Guidance on Switching ART With Viral SuppressionConsiderations for switching to a 2-drug regimen or long-acting ARTMethods for assessing patient satisfaction with their current ART regimenPresenters:Monica Gandhi, MD, MPHDirector, UCSF-Bay Area Center for AIDS Research (CFAR)Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global MedicineMedical Director, “Ward 86” HIV Clinic, San Francisco General HospitalUniversity of California, San Francisco (UCSF)San Francisco, CaliforniaLuis Buzon Martin, MDDivision of Infectious DiseasesHospital Universitario de BurgosBurgos, EspanaLink to full program and accompanying slides: https://bit.ly/3KPN0xbGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Detectable HIV-1 RNA (viral load) can seem very worrisome for people living with HIV who are receiving antiretroviral therapy (ART) and for their healthcare professionals. Tune in to learn how Brian R. Wood, MD, differentiates HIV-1 RNA “blips” from persistent low-level viremia and from virologic failure, and how he handles each scenario.Presenter:Brian R. Wood, MDProfessor of MedicineDivision of Allergy and Infectious DiseasesUniversity of WashingtonSeattle, WashingtonLink to full program: https://bit.ly/4nS7rYEGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune into this podcast from Dr Clíona Ní Cheallaigh to learn how to provide person-centered care for treatment-experienced people with HIV. Gain strategies to address each individual’s specific history and needs while considering the potential impact of comorbidities and other health challenges. Topics covered include:Individualizing Antiretroviral Regimens for Treatment-Experienced People With HIVStrategies to Improve Adherence and Addressing Barriers to Engagement in CarePerson-Centered, Trauma-Informed CareResistance Testing in the Setting of Virologic FailureSelection of ARVs With a Failing RegimenPresenters:Clíona Ní Cheallaigh, MB, MRCP, PhDConsultant PhysicianInclusion Health ServicesSt James’s Hospital DublinAssociate ProfessorDepartment of MedicineTrinity College DublinDublin, IrelandLink to full program:https://bit.ly/4oiYxExGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, expert faculty Atul Humar, MD, FRCP (C), and Camille Kotton, MD, FIDSA, FAST, take a deep dive into complex clinical scenarios and explore designing antiviral regimens for refractory CMV infections to minimize antiviral toxicities and maximize efficacy. Topics covered include:Management for suspected drug-resistant CMV infection Illustrative patient cases Gene mutations in CMV  Presenters:Atul Humar, MD, FRCPC, FASTProfessorDepartment of MedicineUniversity of TorontoEaton Family Chair in Transplant Infectious DiseasesAjmera Transplant CentreUniversity Health NetworkToronto, CanadaCamille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:https://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to learn the fundamentals for timely identification of refractory cytomegalovirus (CMV) infections following solid organ transplantation from expert faculty, Camille Kotton, MD, FIDSA, FAST. Topics covered include:Direct and indirect effects of CMV infectionRisk factors for resistant/refractory CMVDefining resistant/refractory CMVPresenter:Camille Kotton, MD, FIDSA, FAST Clinical Director, Transplant and Immunocompromised Host Infectious DiseasesInfectious Diseases DivisionMass General Brigham Endowed Cancer Chair IVMassachusetts General HospitalAssociate Professor, Harvard Medical SchoolBoston, MassachusettsLink to full program:http://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Learn to appropriately modify antiviral therapy in solid organ transplant recipients with treatment-refractory cytomegalovirus (CMV) infections with expert faculty, Atul Humar, MD, FRCP (C). Topics covered include:Comparisons of available CMV antiviral therapies:Ganciclovir, valganciclovir, foscarnet, cidofovir, maribavirConsiderations for renal function monitoring with ganciclovir and valganciclovirA treatment algorithm for relapsed/refractory CMVThe latest clinical trial data and guideline recommendationsPresenter:Atul Humar, MD, FRCP (C) ProfessorDepartment of MedicineUniversity of TorontoEaton Family Chair in Transplant Infectious DiseasesAjmera Transplant CentreUniversity Health NetworkToronto, CanadaLink to full program:https://bit.ly/4lOa2kAGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable explore strategies for individualization of CMV management in high-risk kidney transplant recipients. Topics include: Risk factors and prevention of late-onset CMV diseaseEarly detection of late CMV infectionCMV cell-mediated immunity monitoringPrimary and secondary prophylaxis Presenters:         Marcus Pereira, MD, MPH, FASTAssociate Professor of MedicineDirector of Clinical Services, Division of Infectious DiseasesMedical Director, Transplant Infectious Disease ProgramColumbia University Irving Medical CenterNew York, New YorkRaymund R. Razonable, MD, FIDSA, FASTProfessor of MedicineDivision of Infectious DiseasesMayo Clinic College of Medicine and ScienceRochester, MinnesotaLink to full program:https://bit.ly/41ejruCGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Marcus Pereira and Dr Raymund R. Razonable discuss the fundamentals of cytomegalovirus (CMV) in kidney transplant recipients. Topics include: CMV pathogenesisDirect and indirect effects of CMV infection Overview of patient risk factorsCMV risk based on serologic status Presenters:         Marcus Pereira, MD, MPH, FASTAssociate Professor of MedicineDirector of Clinical Services, Division of Infectious DiseasesMedical Director, Transplant Infectious Disease ProgramColumbia University Irving Medical CenterNew York, New YorkRaymund R. Razonable, MD, FIDSA, FASTProfessor of MedicineDivision of Infectious DiseasesMayo Clinic College of Medicine and ScienceRochester, MinnesotaLink to full program:https://bit.ly/41ejruCGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: Who should be tested for infectious diarrheaTypes of gastrointestinal syndromic panelsTypes of syndromic panels for joint infectionsReal-world applications for joint syndromic panelsPresenters: Trevor Van Schooneveld, MDProfessor, Division of Infectious DiseasesMedical Director, Antimicrobial Stewardship ProgramDepartment of Internal MedicineUniversity of Nebraska Medical CenterOmaha, NebraskaLink to full program: https://bit.ly/4mHOTtWGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include: Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methodsCharacteristics of available antiviral drugsMonitoring considerations for antiviralsPresenters:        Marcus Pereira, MD, MPH, FASTAssociate Professor of MedicineDirector of Clinical Services, Division of Infectious DiseasesMedical Director, Transplant Infectious Disease ProgramColumbia University Irving Medical CenterNew York, New YorkLink to full program: http://bit.ly/41ejruCGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Alicia Stillman of the American Society for Meningitis Prevention, as she shares a very personal story of loss that might change how you view meningitis vaccination.Presenter:Alicia Stillman, MBA, MPHPatient AdvocateCo-Executive Director, American Society for Meningitis PreventionExecutive Director, Emily Stillman FoundationDetroit, MichiganLink to full program:https://bit.ly/4mYvTXQRegister for the practical symposium:https://bit.ly/4mUOsvVGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:Types of upper and lower respiratory infection panelsConsiderations for when to use respiratory syndromic testingHow to use syndromic testing to guide both therapy escalation and de-escalationHow syndromic testing fits in with traditional testing methods, such as culture, antimicrobial susceptibility testing, Gram stain, and BAL cell count Presenter:Michael Satlin, MD, MS, FIDSAAssociate Professor of Medicine and Pathology and Laboratory MedicineWeill Cornell MedicineNew York, New YorkLink to full program: https://bit.ly/3UAB1oUGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP,andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include: Leveraging pharmacists’ expertise to advance HIV treatmentPharmacist roles in HIV care and management The current ART landscapeRegimen simplificationConsideration of patient preferences, health factors, and comorbidities for ART optimizationART management for treatment-experienced patients, including those with multidrug-resistant HIVPresenters:Alexis E. Horace, PharmD, BCACPProfessor of Pharmacy PracticeUniversity of Louisiana at Monroe College of PharmacyNew Orleans CampusCrescentCare Ambulatory Care Clinical Pharmacist, HIV SpecialtyNew Orleans, LouisianaNimish Patel, PharmD, PhD, AAHIVPProfessor of Clinical PharmacyDivision of Clinical PharmacySkaggs School of Pharmacy & Pharmaceutical SciencesUniversity of California, San DiegoLa Jolla, CaliforniaLink to full program: https://bit.ly/41agtqQGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to learn how the recent FDA approval of lenacapavir (LEN) for PreP integrates into the current field of HIV prevention. Listen on the go or follow along with our expert-curated slides. Topics covered include: The current landscape of PrEPFDA approval of lenacapavirPhase III efficacy and safety data for lenacapavirRecommendations and perspectives on the future of PrEPPresenters:Colleen F. Kelley, MD, MPHProfessor of MedicineDivision of Infectious DiseasesDepartment of MedicineCo-Director, Emory Center for AIDS ResearchAssociated Dean for Research, Emory at GradyEmory University School of MedicineAtlanta, GeorgiaRaphael J. Landovitz, MD, MScProfessor of MedicineChief, Division of Infectious DiseasesAssociate Vice Chair for Clinical ResearchDepartment of MedicineDavid Geffen School of MedicineUniversity of California, Los AngelesDirector, UCLA Center for Clinical AIDS Research & Education (CARE)Director, Center for HIV Identification, Prevention, and Treatment Services (CHIPTS)Los Angeles, CaliforniaLink to full program: https://bit.ly/4m8RaOg Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Hear from experts in HIV care Beatriz Grinsztejn, MD, PhD, and Rosie Mnggibisa, MBChB, MPH, as they discuss their insights on some of the most clinically relevant new data presented at IAS 2025, including studies on: Gaps in care for adolescents and young adults living with HIVGlobal impact of funding cutsAntiretroviral therapy for treating HIVPatient management strategies for people living with HIV and obesityPresenters:Beatriz Grinsztejn, MD, PhDDirectorSTI/HIV Clinical Research LaboratoryEvandro Chagas National Institute of Infectious Diseases – FIOCRUZRio de Janeiro, BrazilRosie Mngqibisa, MBChB, MPHClinical DirectorPrincipal InvestigatorEnhancing Care FoundationDurban, South AfricaLink to full program: https://bit.ly/4otF8AR Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.Topics covered include:The importance of good blood culture practices and finding the balance between overuse and underuseBlood culture improvement programsThe utility of rapid diagnostic testsResistance markers for earlier targeted therapyPresenters:Emily Heil, PharmD, MS, BCIDP, AAHIVPProfessorDepartment of Practice, Sciences, and Health Outcomes ResearchUniversity of Maryland School of PharmacyBaltimore, MarylandLink to full program: https://bit.ly/45Ajz92Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in as Dr George Behrenspresents the fundamentals on specialized agents for treatment-experienced people living with HIV.Topics covered include:Key targets and mechanisms of action for specialized HIV drugsClinical trial data supporting safety and efficacy of these agentsConsiderations for potential drug–drug interactions Strategies for leveraging these agents to construct new ART regimens for treatment-experienced individualsPresenters:Georg Behrens, MDProfessor of ImmunologySenior ConsultantDepartment of Rheumatology and ImmunologyHannover Medical School, GermanyHannover, GermanyLink to full program:https://bit.ly/4oiYxExGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr Josep M. Llibrereviews the essentials on ART selection for treatment-experienced people with HIV and comorbidities. Topics covered include:Underlying reasons for development of multidrug-resistant HIVInflammation and immune activation associated with frequency of age-related conditions General principles for designing ART regimens for persons with multidrug-resistant HIVTreatment options for highly treatment‒experienced peopleConsiderations for comorbidities and drug–drug interactionsPresenters:Josep M. Llibre, MD, PhDSenior ConsultantInfectious Diseases DivisionFight Infections FoundationUniversity Hospital Germans TriasBadalona, Barcelona, SpainLink to full program:https://bit.ly/4oiYxExGet access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.